India’s healthcare sector—particularly its pharmaceutical industry—is entering turbulent waters following President Trump’s announcement on July 30, 2025 of a sweeping 25% tariff on Indian imports, set to take effect from August 1, 2025 (The Washington Post). 🧪 What’s Happening and Why[…]